z-logo
open-access-imgOpen Access
Characteristics of mastoid carcinoma at Otorhinolaryngology Head and Neck Surgery Departement in dr. Zainoel Abidin General Hospital Banda Aceh
Author(s) -
Benny Kurnia,
Baluqia Iskandar Putri
Publication year - 2021
Publication title -
oto rhino laryngologica indonesiana/oto-rhino-laryngologica indonesiana
Language(s) - English
Resource type - Journals
eISSN - 0216-3667
pISSN - 2598-3970
DOI - 10.32637/orli.v51i1.419
Subject(s) - medicine , otorhinolaryngology , stage (stratigraphy) , head and neck surgery , radiation therapy , basal cell , surgery , carcinoma , incidence (geometry) , paleontology , physics , optics , biology
Background: Mastoid carcinoma is a rare case and an aggressive tumor with a poor prognosis. Purpose: To identify the characteristics of mastoid carcinoma in Otorhinolaryngology Head and Neck Surgery Department of dr. Zainoel Abidin Banda Aceh. Method: This study was a descriptive study using medical records data of dr. Zainoel Abidin Hospital Banda Aceh from January 2012 to July 2019 and from the histopathological data as a confirmation. Result: There were 9 cases consisted of 44% male and 56% female with the ratio 1:1,2, in which 41-60 year old were the majority of the patients. Clinical symptoms obtained are otalgia (100%), otorrhea (100%), discharge (100%), facial parental (100%), hearing loss (100%), ear canal mass (100%) and retroauricular mass (44, 4%). The histopathological type of all cases was Squamous Cell Carcinoma (100%). Stage IV of 55.6% and stage III of 44.4% were determined based on CT Scan. Chemotherapy was performed in 89% of patients and 11% of radiotherapy patients. Conclusion: The comparison of male and female mastoid carcinomas is 1:1,2 with a peak incidence at 41-60 years. The histopathological type of all patients was Squamous Cell Carcinoma and based on CT scans found 55.6% of stage IV patients and 44.4% of stage III patients. Chemotherapy was performed in 89% of patients and 11% of radiotherapy patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here